-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the heart blood vessels published a research article on the disease areas authoritative journal Stroke, researchers aimed at a relatively vascular thrombus resection in acute ischemic with and without cerebral amyloid angiopathy (CAA) in stroke patients The ending
.
The researchers included patients with acute ischemic stroke and intravascular thrombectomy with or without possible CAA, and analyzed the subjects' baseline characteristics, surgical parameters, and functional outcomes after 90 days
.
Of the 162 acute ischemic stroke patients, 28 (17.
3%) had CAA diagnosed based on iron-sensitive magnetic resonance imaging before intravascular thrombectomy
diagnosis
The National Institutes of Health Stroke Scale score (adjusted odds ratio is 0.
88; P<0.
001), successful recanalization (adjusted odds ratio is 6.
82; P=0.
005), and CAA (adjusted odds ratio is 0.
28; P= 0.
049) is an independent predictor of outcome
.
Intravenous thrombolysis was associated with an increase in the good outcome of CAA (36.
Intravascular thrombectomy with or without thrombolysis is beneficial to patients with acute ischemic stroke accompanied by CAA, but it is associated with poorer functional outcomes
Original source:
Johannes M.
Weller.
et al.
Endovascular Treatment for Acute Stroke in Cerebral Amyloid Angiopathy .
stroke.
